3 Stocks Tied To Export Control Compliance As Nvidia Questions Spread Bailey Pemberton Wed, November 11, 2026 at 5:12 PM EST 5 min read NVDA EFX RDVT CLBT Explore stocks on Coinbase Trading disclosure Trading disclosure The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Nvidia's recent US$450b valuation hit and the export-control questions swirling around its AI chips have thrown a spotlight on a different kind of opportunity. The plumbing of global trade is suddenly front-page news. Investors watching this saga may find upside or protection in businesses tied to export-control and sanctions compliance. This article unpacks three stocks exposed to that story and why they might matter for your portfolio.
The stocks covered below are only a sample, and the full screen surfaced 17 more export-control and compliance businesses with equally compelling narratives that do not fit into this article. To identify and analyze the highest-conviction ideas tied to this theme, head straight into the Export-Control and Compliance Solutions Providers screener.
Overview: Equifax is a US$ data, analytics, and technology provider that helps businesses and governments verify identities, assess credit risk, and support compliance workflows, including KYC and sanctions screening relevant to export-control monitoring.
Operations: Equifax generates around US$2.7b from Workforce Solutions, US$2.3b from U.S. Information Solutions, and US$1.5b from International operations, with about US$5.1b tied to the United States.
Equifax matters for this export-control and sanctions compliance theme because its identity, credit, and risk datasets underpin the screening pipes regulators and corporates now scrutinise. The analyst consensus Narrative on Simply Wall St argues these datasets are becoming more powerful as recent technology investments start to pay off.
"Accelerating customer adoption of new multi data product solutions such as TWN indicators, Single Data Fabric and EFX.AI, together with the completion of the US$3b cloud transformation, is now being reflected in faster product rollouts and internal productivity gains that support higher EBITDA margins and earnings power."
What happens to those margin ambitions depends on how one unresolved regulatory and litigation pressure point plays out over the next few years.
How that plays out is the real fulcrum for the story, and the full narrative for Equifax explains how Equifax's export-control exposure could either accelerate its earnings power or place a cap on it.
Overview: Cellebrite DI provides software and services that help agencies and corporations extract, analyze, and manage digital evidence for complex, legally sanctioned investigations worldwide.
Operations: Cellebrite DI generates about US$514 million from internet software and services, with revenue of roughly US$275 million from America, US$176 million from EMEA and US$65 million from APAC.
Cellebrite DI matters for this export-control and sanctions theme because its digital investigation tools give regulators and law enforcement a way to uncover evidence around illicit export schemes that would be hard to spot with paperwork checks alone. The analyst consensus Narrative on Simply Wall St takes that enforcement angle seriously when weighing its growth potential.
"The accelerating shift by law enforcement and intelligence agencies toward more advanced digital investigation platforms, supported by products like Genesis, Guardian and Pathfinder that use agentic AI to compress case timelines, continues to support growth in high value subscription ARR and related revenue."
What happens when the current reset in recurring revenue either clears the air or lingers will do most of the work on sentiment.
Whether that reset marks a clean inflection or a drag on sentiment is exactly what the full narrative for Cellebrite DI unpacks, including where Cellebrite DI's enforcement role could accelerate.
Overview: Red Violet provides identity intelligence and analytics that help U.S. businesses and agencies handle due diligence, fraud prevention, and compliance checks.
Operations: Red Violet generates US$103.7 million from Identity and Information Solutions, with all of that revenue currently coming from the United States.
Red Violet matters in this export-control and sanctions compliance theme because its identity data and risk scoring can strengthen counterparty checks. The analyst consensus Narrative on Simply Wall St frames that growing search volume as central to the story.
"Rising identity fraud risk and higher digital transaction volumes, combined with increasing AI and agent-based automation at customers, are expected to push more searches and data transactions through Red Violet's largely volume-driven model."
What happens when that volume trend meets Red Violet's newer AI investments and cash-funded expansion is expected to influence future margins.
That volume and cash story only really comes into focus when you read the full narrative for Red Violet, which lays out how Red Violet could convert usage into durable earnings power.
Markets can move quickly and the cleanest breakout setups can fade before most investors react. Scan fresh ideas while they are still under the radar and consider them before they become widely followed.
Focus on cash-generating opportunities that still trade below intrinsic estimates by reviewing a curated 35 high quality undervalued stocks before they draw broader attention.
Participate in structural AI trends without chasing hype by reviewing a hand-picked pool of 42 profitable AI stocks that aren't just burning cash that already support their narratives with established earnings.
Explore income streams that aim to do more than tread water by screening a curated group of 5 dividend fortresses where payout strength and recent price weakness currently intersect.
This article is general in nature and was produced with the assistance of AI automation, based on data and analysis from Simply Wall St. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
